Clinical Trials Directory

Trials / Completed

CompletedNCT01959022

A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
15 (actual)
Sponsor
San Francisco Veterans Affairs Medical Center · Federal
Sex
All
Age
18 Years – 69 Years
Healthy volunteers
Not accepted

Summary

This study will assess the effects of the medication doxazosin on sleep in men and women with PTSD. Sleep will be measured objectively at home using a portable sleep recorder and wrist actigraphy.

Detailed description

This pilot study will assess the effects of doxazosin on objective measures of sleep in PTSD subjects using home ambulatory polysomnography. Twenty (20) men and women with chronic PTSD will be enrolled at the San Francisco Veterans Affairs Medical Center. After initial screening, subjects will complete 1 week of baseline assessments including 2 nights of home ambulatory polysomnography. They will then participate in a 2-week flexible-dose titration of doxazosin based on clinical response and adverse effects followed by 6 weeks of steady dose treatment ending with 2 nights of home polysomnography. Subjective and rater-based assessments will be conducted at baseline and at set intervals during and at the end of treatment. Wrist actigraphy measurements will also be made at baseline and at end of treatment as an economical, fairly valid and unobtrusive measure of sleep duration. We hypothesize that doxazosin will be associated with an increase in total sleep time (TST) and a decrease in wake time after sleep onset (WASO). We hypothesize that doxazosin will also be associated with clinical gains with respect to nightmares, subjective sleep quality, non-sleep PTSD symptoms, depression symptoms, and quality of life.

Conditions

Interventions

TypeNameDescription
DRUGDoxazosin XLSubjects will participate in a 2 week flexible-dose titration of doxazosin based on clinical response and adverse effects followed by 6 weeks of steady dose treatment.

Timeline

Start date
2013-10-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2013-10-09
Last updated
2016-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01959022. Inclusion in this directory is not an endorsement.